T cell-based therapies have limited success against ovarian cancer for poorly understood reasons. He...
Lipids in ovarian cancer ascites impair T cell activation by disrupting TCR dynamics
T cell-based therapies have limited success against ovarian cancer for poorly understood reasons. Here we show that lipids in ovarian cancer ascites fluid...
Author: Nature
Read Original Article